These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8160697)

  • 1. Stability of ranitidine hydrochloride with ondansetron hydrochloride or fluconazole during simulated Y-site administration.
    Pompilio FM; Fox JL; Inagaki K; Burm JP; Jhee S; Gill MA
    Am J Hosp Pharm; 1994 Feb; 51(3):391-4. PubMed ID: 8160697
    [No Abstract]   [Full Text] [Related]  

  • 2. Compatibility of ondansetron hydrochloride with fluconazole, ceftazidime, aztreonam, and cefazolin sodium under simulated Y-site conditions.
    Bosso JA; Prince RA; Fox JL
    Am J Hosp Pharm; 1994 Feb; 51(3):389-91. PubMed ID: 8160696
    [No Abstract]   [Full Text] [Related]  

  • 3. Stability of paclitaxel with ondansetron hydrochloride or ranitidine hydrochloride during simulated Y-site administration.
    Burm JP; Jhee SS; Chin A; Moon YS; Jeong E; Nii L; Fox JL; Gill MA
    Am J Hosp Pharm; 1994 May; 51(9):1201-4. PubMed ID: 7913797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration.
    Choi JS; Burm JP; Jhee SS; Chin A; Ulrich RW; Gill MA
    Am J Hosp Pharm; 1994 Sep; 51(18):2273-6. PubMed ID: 7801988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
    Inagaki K; Gill MA; Okamoto MP; Takagi J
    J Parenter Sci Technol; 1993; 47(1):35-9. PubMed ID: 8445498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of ranitidine hydrochloride with aztreonam, ceftazidime, or piperacillin sodium during simulated Y-site administration.
    Inagaki K; Gill MA; Okamoto MP; Takagi J
    Am J Hosp Pharm; 1992 Nov; 49(11):2769-72. PubMed ID: 1471644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of ondansetron hydrochloride in syrups compounded from tablets.
    Williams CL; Sanders PL; Laizure SC; Stevens RC; Fox JL; Hak LJ
    Am J Hosp Pharm; 1994 Mar; 51(6):806-9. PubMed ID: 8010321
    [No Abstract]   [Full Text] [Related]  

  • 8. Stability of paclitaxel and fluconazole during simulated Y-site administration.
    Burm JP; Choi JS; Jhee SS; Chin A; Ulrich RW; Gill MA
    Am J Hosp Pharm; 1994 Nov; 51(21):2704-6. PubMed ID: 7856586
    [No Abstract]   [Full Text] [Related]  

  • 9. Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
    McGuire TR; Narducci WA; Fox JL
    Am J Hosp Pharm; 1993 Jul; 50(7):1410-4. PubMed ID: 8362872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of ondansetron hydrochloride injection in extemporaneously prepared oral solutions.
    Graham CL; Dukes GE; Fox JL; Kao CF; Hak LJ
    Am J Hosp Pharm; 1993 Jan; 50(1):106-8. PubMed ID: 8427264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of ranitidine hydrochloride and human insulin in 0.9% sodium chloride injection.
    Nolan PE; Hoyer GL; LeDoux JH; Fox JL
    Am J Health Syst Pharm; 1997 Jun; 54(11):1304-6. PubMed ID: 9179353
    [No Abstract]   [Full Text] [Related]  

  • 12. Stability of labetalol hydrochloride with selected critical care drugs during simulated Y-site injection.
    Hassan E; Leslie J; Martir-Herrero ML
    Am J Hosp Pharm; 1994 Sep; 51(17):2143-5. PubMed ID: 7985689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
    Trissel LA; Tramonte SM; Grilley BJ
    Am J Hosp Pharm; 1991 May; 48(5):988-92. PubMed ID: 1830190
    [No Abstract]   [Full Text] [Related]  

  • 14. Compatibility of ondansetron hydrochloride with meperidine hydrochloride for combined administration.
    Xu QA; Trissel LA; Fox JL
    Ann Pharmacother; 1995 Nov; 29(11):1106-9. PubMed ID: 8573953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of ranitidine hydrochloride with eight medications in intravenous admixtures.
    Galante LJ; Stewart JT; Warren FW; Edgar JW; Huff AJ
    Am J Hosp Pharm; 1990 Jul; 47(7):1606-10. PubMed ID: 2368759
    [No Abstract]   [Full Text] [Related]  

  • 16. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
    Lor E; Sheybani T; Takagi J
    Am J Hosp Pharm; 1991 Apr; 48(4):744-6. PubMed ID: 2042678
    [No Abstract]   [Full Text] [Related]  

  • 17. Stability of ondansetron hydrochloride and cyclophosphamide in injectable solutions.
    Fleming RA; Olsen DJ; Savage PD; Fox JL
    Am J Health Syst Pharm; 1995 Mar; 52(5):514-6. PubMed ID: 7606557
    [No Abstract]   [Full Text] [Related]  

  • 18. Stability of ondansetron hydrochloride and 12 medications in plastic syringes.
    Stewart JT; Warren FW; King DT; Venkateshwaran TG; Fox JL
    Am J Health Syst Pharm; 1998 Dec; 55(24):2630-4. PubMed ID: 9872702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability and compatibility of fluconazole and aminophylline in intravenous admixtures.
    Johnson CE; Jacobson PA; Pillen HA; Woycik CL
    Am J Hosp Pharm; 1993 Apr; 50(4):703-6. PubMed ID: 8470689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administration.
    Chung KC; Moon YS; Chin A; Ulrich RW; Gill MA
    Am J Health Syst Pharm; 1995 Jul; 52(14):1554-6. PubMed ID: 7552901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.